These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9119072

  • 21. Inactivation of Soybean Bowman-Birk Inhibitor by Stevioside: Interaction Studies and Application to Soymilk.
    Liu C, Luo L, Wu Y, Yang X, Dong J, Luo F, Zou Y, Shen Y, Lin Q.
    J Agric Food Chem; 2019 Feb 27; 67(8):2255-2264. PubMed ID: 30729785
    [Abstract] [Full Text] [Related]

  • 22. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A.
    Arch Med Res; 2014 Aug 27; 45(6):455-61. PubMed ID: 25014623
    [Abstract] [Full Text] [Related]

  • 23. Proteinase inhibition using small Bowman-Birk-type structures.
    Fernandez JH, Mello MO, Galgaro L, Tanaka AS, Silva-Filho MC, Neshich G.
    Genet Mol Res; 2007 Oct 05; 6(4):846-58. PubMed ID: 18058707
    [Abstract] [Full Text] [Related]

  • 24. c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor.
    Caggana M, Kennedy AR.
    Carcinogenesis; 1989 Nov 05; 10(11):2145-8. PubMed ID: 2509094
    [Abstract] [Full Text] [Related]

  • 25. A Bowman-Birk inhibitor with anti-elastase activity from Lathyrus sativus L. seeds.
    Rocco M, Malorni L, Chambery A, Poerio E, Parente A, Di Maro A.
    Mol Biosyst; 2011 Aug 05; 7(8):2500-7. PubMed ID: 21647515
    [Abstract] [Full Text] [Related]

  • 26. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
    Gladysheva IP, Moroz NA, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Larionova NI.
    J Drug Target; 2001 Aug 05; 9(5):303-16. PubMed ID: 11770701
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Studies on soybean trypsin inhibitors. X. Isolation and partial characterization of four soybean double-headed proteinase inhibitors.
    Odani S, Ikenaka T.
    J Biochem; 1977 Dec 05; 82(6):1513-22. PubMed ID: 599140
    [Abstract] [Full Text] [Related]

  • 34. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T.
    Cancer Lett; 2007 Aug 18; 253(2):249-57. PubMed ID: 17343982
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Molecular engineering of a small trypsin inhibitor based on the binding loop of horsegram seed Bowman-Birk inhibitor.
    Muricken DG, Gowda LR.
    J Enzyme Inhib Med Chem; 2011 Aug 18; 26(4):553-60. PubMed ID: 21171897
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH.
    Carcinogenesis; 1991 May 18; 12(5):935-7. PubMed ID: 2029760
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.